198 related articles for article (PubMed ID: 7680967)
1. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
Grunwald U; Krüger C; Schütt C
Circ Shock; 1993 Mar; 39(3):220-5. PubMed ID: 7680967
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N
Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
[TBL] [Abstract][Full Text] [Related]
3. sCD14 prevents endotoxin inducible oxidative burst response of human monocytes.
Schütt C; Schilling T; Krüger C
Allerg Immunol (Leipz); 1991; 37(3-4):159-64. PubMed ID: 1724353
[TBL] [Abstract][Full Text] [Related]
4. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
Corrales I; Weersink AJ; Verhoef J; van Kessel KP
Immunology; 1993 Sep; 80(1):84-9. PubMed ID: 7503949
[TBL] [Abstract][Full Text] [Related]
5. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
Heumann D; Gallay P; Barras C; Zaech P; Ulevitch RJ; Tobias PS; Glauser MP; Baumgartner JD
J Immunol; 1992 Jun; 148(11):3505-12. PubMed ID: 1375247
[TBL] [Abstract][Full Text] [Related]
6. Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes.
Pedron T; Girard R; Chaby R
J Immunol; 1995 Aug; 155(3):1460-71. PubMed ID: 7543522
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
[TBL] [Abstract][Full Text] [Related]
8. Binding sites for endotoxins (lipopolysaccharides) on human monocytes.
Couturier C; Haeffner-Cavaillon N; Caroff M; Kazatchkine MD
J Immunol; 1991 Sep; 147(6):1899-904. PubMed ID: 1716284
[TBL] [Abstract][Full Text] [Related]
9. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
[TBL] [Abstract][Full Text] [Related]
10. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood.
Haziot A; Rong GW; Bazil V; Silver J; Goyert SM
J Immunol; 1994 Jun; 152(12):5868-76. PubMed ID: 7515917
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the endotoxin receptor (CD14) in septic patients.
Birkenmaier C; Hong YS; Horn JK
J Trauma; 1992 Apr; 32(4):473-8; discussion 478-9. PubMed ID: 1373777
[TBL] [Abstract][Full Text] [Related]
12. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.
Gallay P; Jongeneel CV; Barras C; Burnier M; Baumgartner JD; Glauser MP; Heumann D
J Immunol; 1993 Jun; 150(11):5086-93. PubMed ID: 7684419
[TBL] [Abstract][Full Text] [Related]
13. Modulation of lipopolysaccharide binding to human granulocytes.
Weersink AJ; Van Kessel KP; Van der Tol ME; Verhoef J
Immunology; 1994 Dec; 83(4):617-23. PubMed ID: 7533136
[TBL] [Abstract][Full Text] [Related]
14. Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
Antal-Szalmás P; Poppelier MJ; Broekhuizen R; Verhoef J; van Strijp JA; van Kessel KP
Cytometry; 2000 Dec; 41(4):279-88. PubMed ID: 11084613
[TBL] [Abstract][Full Text] [Related]
15. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.
Haziot A; Rong GW; Silver J; Goyert SM
J Immunol; 1993 Aug; 151(3):1500-7. PubMed ID: 7687634
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin-neutralizing capacity of soluble CD14.
Schütt C; Schilling T; Grunwald U; Schönfeld W; Krüger C
Res Immunol; 1992 Jan; 143(1):71-8. PubMed ID: 1373513
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
Golenbock DT; Bach RR; Lichenstein H; Juan TS; Tadavarthy A; Moldow CF
J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
[TBL] [Abstract][Full Text] [Related]
18. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria.
Jack RS; Grunwald U; Stelter F; Workalemahu G; Schütt C
Eur J Immunol; 1995 May; 25(5):1436-41. PubMed ID: 7539760
[TBL] [Abstract][Full Text] [Related]
19. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis.
Labeta MO; Durieux JJ; Spagnoli G; Fernandez N; Wijdenes J; Herrmann R
Immunology; 1993 Nov; 80(3):415-23. PubMed ID: 7507090
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.
von Asmuth EJ; Dentener MA; Bazil V; Bouma MG; Leeuwenberg JF; Buurman WA
Immunology; 1993 Sep; 80(1):78-83. PubMed ID: 7503948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
